UPDF AI

New Pathogenic Paradigms in Inflammatory Bowel Disease

A. Di Sabatino,P. Biancheri,2 Authors,G. Corazza

2012 · DOI: 10.1002/ibd.21735
Inflammatory Bowel Diseases · 89 Citations

TLDR

The T helper cell type (Th)1/Th2 paradigm has been outdated thanks to the advances in understanding the function of Th17 cells and these new paradigms, together with the no longer "static" but "dynamic" vision of intestinal inflammation, highlight new possible therapeutic targets in inflammatory bowel disease.